Skip to main content
SpringerLink
Log in

Lenalidomide [Revlimid] has received a preliminary positive recommendation from NICE for use in the NHS in England and Wales

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Celgene International Sárl.REVLIMID (Rm) Receives Preliminary Positive Recommendation from National Institute for Health and Clinical Excellence (NICE) for Use in the National Health Service (NHS) in England and Wales. Media Release: 30 Jan 2009. Available from: URL: http://www.celgene.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lenalidomide [Revlimid] has received a preliminary positive recommendation from NICE for use in the NHS in England and Wales. Pharmacoecon. Outcomes News 573, 10 (2009). https://doi.org/10.2165/00151234-200905730-00030

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905730-00030

Keywords

Search

Navigation